Arkolith/Insider Trading/CERO/Form 4/A

Laporte Kathleen

DirectorCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4/A · filed Feb 21, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Grant(A)50$1000.00$50K50

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-24-015876) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML